Loading organizations...
LoftyRock Investment operates as an asset management firm, focusing on venture capital and private equity. The firm targets companies demonstrating disruptive innovation, employing a rigorous analytical framework to cultivate growth across diverse sectors. Its approach emphasizes strategic partnerships, building a resilient portfolio of high-potential enterprises.
Dohyung Kim established LoftyRock Investment in 2021, serving as CEO. Mr. Kim founded the firm with over two decades of experience in management consulting, corporate strategy, and investment. His extensive background, including a pivotal role in DongKoo Bio & Pharma's public listing, informed his vision for backing innovative ventures.
LoftyRock Investment partners with investors seeking substantial returns and collaborates with founders driving innovative ideas. The firm's philosophy reflects a continuous pursuit of investor value and the cultivation of a stable foundation of portfolio companies. Its long-term vision centers on empowering transformative innovation for a better future.
LoftyRock Investment has 1 tracked investment across 1 company. The latest tracked deal is $60.0M Series B in BreezeBio in February 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 25, 2026 | BreezeBio | $60.0M Series B | DSC Investment | Acvc Partners, Daily Partners, Kiwoom Investment, Korea Development Bank, Korea Investment Partners, Pathway Capital Management, Stic Ventures, SV Investment, TOP Harvest Capital, Woori Venture Partners |
